Victoria Vakiener, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 1,550 shares at $26.33 ($41K) on 2023-09-28, disclosed to the SEC on 2023-10-02.
Open-market sale of $41k ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARWR | SELL | 2024-05-06 | $42K | — | Filing → |
| ARWR | SELL | 2024-01-16 | $317K | — | Filing → |
| EPZM | SELL | 2021-02-05 | $9K | — | Filing → |